Incepted in 1993, the Biotechnology R&D Division at EIPW conducts advanced research in the area of microbial biotechnology and recombinant DNA technology. This lab, equipped with modern sophisticated infrastructure and expert scientists and technicians, is recognized by DSIR (Department of Scientific and Industrial Research), DBT (Department of Biotechnology) and BARC (Bhabha Atomic Research Centre), Govt. of India.

The research in Biotechnology Division has progressed through several in-house projects involving genetic engineering of bacteria and filamentous fungi, microbial fermentation, down-stream processing, therapeutic enzymes and probiotics. Some targeted products developed by this department include probiotic formulations and formulations with therapeutic enzymes in the segment of digestive and inflammatory disorders. This division is also working towards the

The research in Biotechnology Division has progressed through several in-house projects involving genetic engineering of bacteria and filamentous fungi, microbial fermentation, down-stream processing, therapeutic enzymes and probiotics. Some targeted products developed by this department include probiotic formulations and formulations with therapeutic enzymes in the segment of digestive and inflammatory disorders. This division is also working towards the development of products in the field of anti-infective and development of PCR based identification kit for pathogenic enteric bacteria. A Patent on ‘genetically modified Aspergillus oryzae’ was awarded to EIPW in 2010.

Collaborative research projects with academic institutions like Indian Institute of Chemical Biology, Kolkata; The Cleveland Clinic Foundation, Cleveland, Ohio, USA; National Institute of Cholera and Enteric Diseases, Kolkata and National Chemical Laboratory, Pune and industrial organizations like Astra Zeneca Pharma India Ltd, Bangalore, too have taken up for certain areas of biotechnology, modern medicines and ayurvedic formulations.